Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods

Data source

Reference
Reference Type:
publication
Title:
The effects of oats on the function of gut microflora in children with coeliac disease
Author:
Tjellström B, Stenhammar L, Sundqvist T, Fälth-Magnusson K, Hollén E, Magnusson KE, Norin E, Midtvedt T, Högberg L.
Year:
2014
Bibliographic source:
Aliment Pharmacol Ther., 39(10):1156-60
Report date:
2014

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Clinical study, randomised double-blind study on the effect of a gluten-free diet containing oats (GFD-oats) vs a standard GDF (GFD-std). Faecal samples were received from 34 children in the GFD-oats group and 37 in the GFD-std group at initial diagnosis and/or after 1 year on a GFD. Faecal short chain fatty acids (SCFAs) were analysed.
GLP compliance:
no
Test type:
other: clinical study

Test material

Constituent 1
Reference substance name:
Oat, ext.
EC Number:
281-672-4
EC Name:
Oat, ext.
Cas Number:
84012-26-0
Molecular formula:
(C2H4O)n
IUPAC Name:
Avena Sativa (Oat) leaf/stem extract Avena sativa extract Oat, ext.

Results and discussion

Effect levels
Key result
Dose descriptor:
LD50
Effect level:
> 93 000 mg/kg bw
Clinical signs:
other:
Other findings:
The GFD-std group had a significantly lower total faecal SCFA concentration at 12 months compared with 0 months (P < 0.05). In contrast, total SCFA in the GFD-oats group remained high after 1 year on the GFD. The children in the GFD-oats group had significantly higher acetic acid (P < 0.05), n-butyric acid (P < 0.05) and total SCFA concentration (P < 0.01) after 1-year diet treatment compared to the GFD-std group.
Good systemic tolerance at 50 and 93 g per day in 23 and 18 persons, except intestinal inflammation, which could occur in coealic patients - LD50 >93000 mg/kg.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In a clinical study, gluten-free diet containing oats (GFD-oats) had a good systemic tolerance at 50 and 93 g per day in 23 and 18 persons, except intestinal inflammation, which could occur in coealic patients.
LD50 can be estimated to be >93000 mg/kg.